Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19

Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhouderi, Eiman, Elsawalhy, Eman, Kabbani, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224764/
https://www.ncbi.nlm.nih.gov/pubmed/35755512
http://dx.doi.org/10.7759/cureus.25264
_version_ 1784733448512995328
author Elhouderi, Eiman
Elsawalhy, Eman
Kabbani, Mohamed
author_facet Elhouderi, Eiman
Elsawalhy, Eman
Kabbani, Mohamed
author_sort Elhouderi, Eiman
collection PubMed
description Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment.
format Online
Article
Text
id pubmed-9224764
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-92247642022-06-24 Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19 Elhouderi, Eiman Elsawalhy, Eman Kabbani, Mohamed Cureus Cardiology Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment. Cureus 2022-05-23 /pmc/articles/PMC9224764/ /pubmed/35755512 http://dx.doi.org/10.7759/cureus.25264 Text en Copyright © 2022, Elhouderi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Elhouderi, Eiman
Elsawalhy, Eman
Kabbani, Mohamed
Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
title Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
title_full Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
title_fullStr Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
title_full_unstemmed Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
title_short Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
title_sort myopericarditis after mrna covid-19 vaccine in a patient with recent history of covid-19
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224764/
https://www.ncbi.nlm.nih.gov/pubmed/35755512
http://dx.doi.org/10.7759/cureus.25264
work_keys_str_mv AT elhouderieiman myopericarditisaftermrnacovid19vaccineinapatientwithrecenthistoryofcovid19
AT elsawalhyeman myopericarditisaftermrnacovid19vaccineinapatientwithrecenthistoryofcovid19
AT kabbanimohamed myopericarditisaftermrnacovid19vaccineinapatientwithrecenthistoryofcovid19

Ejemplares similares